Literature DB >> 5430786

Studies on the origin of human leukocytic pyrogen.

J J Nordlund, R K Root, S M Wolff.   

Abstract

Release of the protein molecule, leukocytic pyrogen, is one of the many reactions exhibited by leukocytes after phagocytosis. After the ingestion of heat-killed S. albus, a 3-4 hr latent period exists, during which human peripheral leukocytes release no pyrogen, yet cellular metabolism is altered in such a way that pyrogen output may subsequently occur in the absence of further phagocytosis. Transcription of messenger RNA and translation of new protein are initial events in the. activation process, since addition of the inhibitors, actinomycin D, and cycloheximide or puromycin, during this period markedly depressed or abolished subsequent pyrogen release. These effects were noted to be dependent upon the time of addition of the inhibitors. None of the inhibitor drugs interfered with cell viability as measured by phagocytosis and hexose monophosphate shunt activity, nor did they alter the pyrogenicity of preformed leukocytic pyrogen. Vincristine did not inhibit pyrogen formation, consistent with its reported failure to alter RNA synthesis in mature human granulocytes. The glycolytic inhibitor, sodium fluoride, blocked pyrogen release both when added prior to particle ingestion or 1 hr after the initiation of phagocytosis. Whereas inhibition of phagocytosis would explain the sodium fluoride effect prior to 1 hr, this was not observed in leukocyte preparations incubated for 1 hr with S. albus before adding sodium fluoride. When sodium fluoride was added to preparations 2 hr after the start of incubation, the LP production was unimpaired. Potassium cyanide had no effect on cell activation or pyrogen release. These findings suggest that the primary energy supply for the activation process is derived from high energy phosphate bonds provided by anaerobic glycolysis. Since the major amount of cell activation appears to occur in the 1st hr after phagocytosis, this energy might be involved in the induction of a genome leading to the transcription of m-RNA and its translation into new protein or is required for polysome integrity during protein synthesis. It is suggested that this new protein may be leukocytic pyrogen itself, or an enzyme responsible for cleaving it from an inactive precursor.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5430786      PMCID: PMC2138772          DOI: 10.1084/jem.131.4.727

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  32 in total

1.  PUROMYCIN INHIBITION OF PROTEIN SYNTHESIS: INCORPORATION OF PUROMYCIN INTO PEPTIDE CHAINS.

Authors:  D NATHANS
Journal:  Proc Natl Acad Sci U S A       Date:  1964-04       Impact factor: 11.205

2.  The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes.

Authors:  A J SBARRA; M L KARNOVSKY
Journal:  J Biol Chem       Date:  1959-06       Impact factor: 5.157

3.  The mechanism of steroid-induced fever.

Authors:  P T Bodel; M Dillard; P K Bondy
Journal:  Ann Intern Med       Date:  1968-11       Impact factor: 25.391

4.  Ribonucleic acid biosynthesis in human leukocytes. Effects of phagocytosis on RNA metabolism.

Authors:  M J Cline
Journal:  Blood       Date:  1966-08       Impact factor: 22.113

5.  Human leukocyte pyrogen producing fever in rabbits.

Authors:  P Bodel; E Atkins
Journal:  Proc Soc Exp Biol Med       Date:  1966-03

6.  Energy requirement for the incorporation of amino acids into protein of isolated mouse-liver mitochondria.

Authors:  P F Delaney; N J Girardot
Journal:  J Cell Physiol       Date:  1966-08       Impact factor: 6.384

7.  Studies on steroid fever: I. Production of leukocyte pyrogen in vitro by etiocholanolone.

Authors:  P Bodel; M Dillard
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

8.  Studies on the pathogenesis of fever. 18. Activation of leukocytes for pyrogen production.

Authors:  D M Moore; S F Cheuk; J D Morton; R D Berlin; W B Wood
Journal:  J Exp Med       Date:  1970-01-01       Impact factor: 14.307

9.  Studies on the pathogenesis of fever. X. The effect of certain enzyme inhibitors on the production and activity of leucocvtic pvrogen.

Authors:  H K KAISER; W B WOOD
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

10.  Studies on the pathogenesis of fever. XIV. Further observations on the chemistry of leukocytic pyrogen.

Authors:  G W Rafter; S F Cheuk; D W Krause; W B Wood
Journal:  J Exp Med       Date:  1966-03-01       Impact factor: 14.307

View more
  22 in total

1.  On the mechanism of pyrogenic action of ricin.

Authors:  G A Balint
Journal:  Experientia       Date:  1976

2.  Human leukocytic pyrogen: purification and development of a radioimmunoassay.

Authors:  C A Dinarello; L Renfer; S M Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

3.  Studies on the mechanism of endogenous pyrogen production. II. Role of cell products in the regulation of pyrogen release from blood leukocytes.

Authors:  P Bodel
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

Review 4.  Temperature and host defense.

Authors:  N J Roberts
Journal:  Microbiol Rev       Date:  1979-06

5.  Hypothermia during chemotherapy for Hodgkin's disease.

Authors:  M J Jackson; S J Proctor; R C Leonard
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-09

Review 6.  Molecular mechanisms in endotoxin fever.

Authors:  C A Dinarello
Journal:  Agents Actions       Date:  1983-08

7.  Studies on the active site of human leukocytic pyrogen.

Authors:  C A Dinarello; K Bendtzen; S M Wolff
Journal:  Inflammation       Date:  1982-03       Impact factor: 4.092

Review 8.  Production of fever and its effects on the host.

Authors:  C A Dinarello; S M Wolff
Journal:  Klin Wochenschr       Date:  1982-07-15

9.  The Jeremiah Metzger Lecture. The pathogenesis of fever in human subjects.

Authors:  S M Wolff; C A Dinarello
Journal:  Trans Am Clin Climatol Assoc       Date:  1980

10.  The production of antibody against human leukocytic pyrogen.

Authors:  C A Dinarello; L Renfer; S M Wolff
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.